These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8907296)

  • 21. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thrombocyte values during ergenyl treatment].
    Stolzis L; Scheffner D
    Bibl Psychiatr; 1975; (151):161-5. PubMed ID: 1098651
    [No Abstract]   [Full Text] [Related]  

  • 23. Protein binding of valproic acid in Japanese pediatric and adult patients with epilepsy.
    Kodama Y; Kodama H; Kuranari M; Tsutsumi K; Ono S; Yamaguchi T; Fujimura A
    Am J Health Syst Pharm; 2002 May; 59(9):835-40. PubMed ID: 12004461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hallucinations after withdrawal of valproic acid.
    de Laat SA; Hillegers MH; Jansen FE; Braun KP; de Graeff-Meeder ER
    Pediatrics; 2012 Jul; 130(1):e236-8. PubMed ID: 22689876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ketogenic diet and other dietary therapies on anti-epileptic drug concentrations in patients with epilepsy.
    Heo G; Kim SH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):758-764. PubMed ID: 28626875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 27. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe bleeding complications during antiepileptic treatment with valproic acid in children.
    Cannizzaro E; Albisetti M; Wohlrab G; Schmugge M
    Neuropediatrics; 2007 Feb; 38(1):42-5. PubMed ID: 17607605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy.
    Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E
    Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of valproic acid-associated weight gain in prepubertal children.
    Espinosa PS; Salazar JC; Yu L; Mendiondo MS; Robertson WC; Baumann RJ
    Pediatr Neurol; 2008 Sep; 39(3):177-80. PubMed ID: 18725062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The normalization period of platelet aggregation in newborns.
    Tanindi S; Kürekçi AE; Köseoğlu V; Kurt M; Ozcan O
    Thromb Res; 1995 Oct; 80(1):57-62. PubMed ID: 8578538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute hepatic failure associated with valproic acid in children. Report of 3 cases].
    Antoniuk SA; Bruck I; Hönnicke LR; Martins LT; Carreiro JE; Cat R
    Arq Neuropsiquiatr; 1996 Dec; 54(4):652-4. PubMed ID: 9201347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do epileptic children treated with valproate have a risk of excessive weight gain?
    Bosnak M; Dikici B; Haspolat K; Dagli A; Dikici S
    J Child Neurol; 2003 Apr; 18(4):306; author reply 306. PubMed ID: 12760438
    [No Abstract]   [Full Text] [Related]  

  • 34. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 35. Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?
    Lackmann GM
    Pharmacology; 2004 Feb; 70(2):57-8. PubMed ID: 14685007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine or valproic acid.
    Prodam F; Bellone S; Casara G; De Rienzo F; Grassino EC; Bonsignori I; Demarchi I; Rapa A; Radetti G; Bona G
    Epilepsia; 2010 Feb; 51(2):312-5. PubMed ID: 19780793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of valproic acid in children with severe epilepsy: clearance and hepatotoxicity.
    Dodson WE; Tasch V
    Neurology; 1981 Aug; 31(8):1047-50. PubMed ID: 6791048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy.
    Grosso S; Mostardini R; Piccini B; Balestri P
    Ann Pharmacother; 2009 Jan; 43(1):45-50. PubMed ID: 19066323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative valproate administration does not increase blood loss during temporal lobectomy.
    Ward MM; Barbaro NM; Laxer KD; Rampil IJ
    Epilepsia; 1996 Jan; 37(1):98-101. PubMed ID: 8603633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.